PEG3 and neoplasm: We found that knockdown of Peg3 significantly attenuated mTOR hyperactive HCC tumorigenesis and metastasis using subcutaneous xenograft mouse model and tail-vein intravenous injection in vivo, indicated by tumor volume, tumor weight, and lung metastasis (Figure 6F-K).